Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,497.7
-3.1 (-0.12%)

 

  • STI Straits Times Index
    2,497.7
    -3.1 (-0.12%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,506.6
    -6.4 (-0.43%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,455.4
    114.6 (0.47%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,338.1
    67.7 (2.07%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,360.3
    40.9 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,059.2
    20.8 (0.41%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,595.1M
  • Value: 1,877.8M
  • Rise: 152
  • Fall: 154
  • Unch: 475

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.157-0.008
Oceanus^0.007-
Frasers L&C Tr1.420+0.010
NetLink NBN Tr0.965-0.010
Jiutian Chemical0.045-
Alset0.063+0.002
Rex Intl0.156+0.003
HPH Trust USD0.132+0.007
Golden Agri-Res0.141-0.001
Medtecs Intl1.070-0.110

World Indices

World Indices
Name Last Change
Nasdaq 10,793.3 -117.0
HSI 24,455.4 +114.6
HSCEI 9,803.1 +71.0
Jakarta 5,059.2 +20.8
Nikkei 225 23,360.3 +40.9
SSE Comp 3,338.1 +67.7
Shanghai A 3,498.5 +71.0
Shanghai B 251.8 +1.7
KOSPI 2,412.4 +6.2

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ALLOVIR INC ALLOVIR
Updated on 18 Sep 2020 (End of trading day)
Last (USD): 29.580 Change: +3.530 High: 31.750 Remarks: -
Change (%): +13.55 Low: 25.001
Open 26.160 Yesterday's Close 26.049999999999997
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 2,975,560 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.36615 Trailing EPS (USD) e -0.36615 NAV (USD) b -1.0950
PE a - Trailing PE f - Price / NAV b -27.0137
Dividend (USD) d - Cash In Hand (USD) g 1.2021 Issued & Paid-up Shares c 65,106,900
Dividend Yield (%) d - Price / Cash In Hand g 24.607 Treasury Shares h 6,209,942
Market Cap (M) 1,925.862 Enterprise Value (M) 2,004.783
Piotroski F Score 3 Exchange Code ALVR Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 45.6
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 27 Jul 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ALLOVIR INC NASDAQ 1,925.862 - - -27.0137 -
Industry Biotechnology NASDAQ 2,774.068 680.915 6455.431 6.8153 0.649
Local Peer AMGEN INC NASDAQ 145,088.118 18.501 19.878 13.6118 2.364
Local Peer GILEAD SCIENCES INC NASDAQ 81,554.486 15.142 - 4.5240 3.912
Local Peer VERTEX PHARMACEUTICAL NASDAQ 69,125.337 58.740 33.221 9.1931 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 59,073.077 27.920 19.800 6.5221 -
Local Peer BIOGEN INC NASDAQ 43,453.752 7.379 7.332 3.8425 -
Local Peer ILLUMINA INC NASDAQ 43,143.000 43.057 62.255 9.4550 -
Local Peer SEATTLE GENETICS INC NASDAQ 31,483.017 - - 17.3549 -
Local Peer MODERNA INC NASDAQ 27,569.794 - - 9.3555 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,924.354 10.367 29.458 2.3758 -
Local Peer BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS NASDAQ 24,766.176 - - 9.7648 -
Local Peer IMMUNOMEDICS INC NASDAQ 19,770.858 - - 33.3229 -
Local Peer INCYTE CORPORATION NASDAQ 18,980.886 42.472 - 8.0956 -
Other Local Peers BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), 10X GENOMICS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), ACCELERON PHARMA (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), ALKERMES PLC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), VAXCYTE INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), XENCOR INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), VERACYTE INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), MACROGENICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), CORTEXYME INC (NASDAQ), VIELA BIO INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), CYTOKINETICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), REGENXBIO INC (NASDAQ), ALECTOR INC (NASDAQ), NKARTA INC (NASDAQ), ARVINAS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), AGENUS INC (NASDAQ), PERSONALIS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), NANTKWEST INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), AKOUOS INC (NASDAQ), VAXART INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), PRECIGEN INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), PASSAGE BIO INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), IMMUNOGEN INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), INHIBRX INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), XBIOTECH INC (NASDAQ), GERON CORP (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVROBIO INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), IMMATICS N V (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ARDELYX INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ATRECA INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), ANAPTYSBIO INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), HUMANIGEN INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), KAMADA (NASDAQ), PDL BIOPHARMA INC (NASDAQ), MERUS B V (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), IMV INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), AFFIMED N V (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), CABALETTA BIO INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), NEXTCURE INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), MEDICINOVA INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), VERASTEM INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), ADURO BIOTECH INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), XOMA CORP (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHIMERIX INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), EQUILLIUM INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SESEN BIO INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), CELYAD ONCOLOGY ADS EACH REPR 1 ORD (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), INFLARX N V (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), LUMOS PHARMA INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), ORGENESIS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), VACCINEX INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), ARAVIVE INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), RESTORBIO INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), SYNLOGIC INC (NASDAQ), SAVARA INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), COHBAR INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), SOLIGENIX INC (NASDAQ), RECRO PHARMA INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), BIOVIE INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ATYR PHARMA INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), PRECIPIO INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), BIOCARDIA INC (NASDAQ), ADVAXIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), HISTOGEN INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), SENESTECH INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ)
Global Peer AMGEN-T HKEx 1,083,533.900 17.635 19.045 13.1159 2.480
Global Peer CSL ASX 128,568.360 40.993 40.993 13.5612 1.039
Global Peer WUXI BIO HKEx 256,997.050 223.558 178.482 17.2043 -
Global Peer BEIGENE HKEx 196,260.070 - - 9.9840 -
Global Peer SINO BIOPHARM HKEx 168,532.318 54.910 61.280 4.8811 0.595
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 5,323.716 97.683 31.261 4.4409 -
Global Peer Lonza SGX 5,940.891 6.617 5.028 0.6269 4.784
Global Peer GENSCRIPT BIO HKEx 26,105.835 - - 3.5705 -
Global Peer 3SBIO HKEx 22,866.515 20.710 15.229 1.9549 -
Global Peer VIVA BIOTECH HKEx 18,455.123 61.214 - 8.8714 0.169
Other Global Peers HAOHAI BIOTEC (HKEx), ALPHAMAB-B (HKEx), MESOBLAST LTD (ASX), MYOVANT SCIENCES LTD (NYSE), ARCUS BIOSCIENCES INC (NYSE), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), ASCENTAGE-B (HKEx), KADMON HLDGS INC (NYSE), KINTOR PHARMA-B (HKEx), DPHARMA (Bursa), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), LEE'S PHARM (HKEx), ESSEX BIO-TECH (HKEx), TELIX PHARMACEUTIC (ASX), PFENEX INC (NYSE American), NANOVIRICIDES INC (NYSE American), IBIO INC (NYSE American), NEXT SCIENCE LTD (ASX), IMUGENE LIMITED (ASX), LINEAGE CELL THERAPEUTICS INC (NYSE American), CEL-SCI CORP (NYSE American), ENZO BIOCHEM INC (NYSE), IMMUTEP LTD (ASX), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), ANTEOTECH LIMITED (ASX), CYNATA THERAPEUTICS LTD (ASX), AIM IMMUNOTECH INC (NYSE American), PALATIN TECHNOLOGIES INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), BIONOMICS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), MEMPHASYS LTD (ASX), GENETIC TECHNOLOGIES (ASX), INVEX THERAPEUTICS LTD NPV (ASX), BIOTRON (ASX), CT ENTERPRISE (HKEx), ALTERITY THERAPEUTICS LIMITED (ASX), REGENEUS LTD (ASX), REGENT PACIFIC (HKEx), INDIA GLOBALIZATION CAPITAL INC (NYSE American), ORAGENICS INC (NYSE American), Suntar Eco-City (SGX), PRESCIENT THERAPEUTICS LIMITED (ASX), BIOSINO BIO-TEC (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), RHINOMED LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), ACTINOGEN MEDICAL LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), HOLISTA COLLTECH LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), AUSTRALIAN PRIMARY HEMP LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), CRYOSITE (ASX), LIVING CELL TECHNOLOGIES (ASX), NANOLLOSE LTD (ASX), HAO WEN HLDGS (HKEx), LEAF RESOURCES LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+7.560
+34.33 %
10 Days -+4.810
+19.42 %
20 Days --2.180
-6.86 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 18.150 - 45.280 Change From 1 Year Low +11.430 % Change From 1 Year Low (%) +62.98
Change From 1 Year High -15.700 % Change From 1 Year High (%) -34.67
2 Years Range 18.150 - 45.280 Change From 2 Years Low +11.430 % Change From 2 Years Low (%) +62.98
Change From 2 Years High -15.700 % Change From 2 Years High (%) -34.67
5 Years Range 18.150 - 45.280 Change From 5 Years Low +11.430 % Change From 5 Years Low (%) +62.98
Change From 5 Years High -15.700 % Change From 5 Years High (%) -34.67
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

AlloVir, Inc. engages in the research, development and commercialization of off-the-shelf VST therapies to prevent and treat severe viral-associated diseases. It develops novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems. The firm's technology platforms deliver commercially scalable solutions by leveraging off-the-shelf, allogeneic, multi-virus specific T-cells targeting devastating viral pathogens for immunocompromised patients under viral attack. The company was founded by Malcolm K. Brenner, Juan F. Vera, Helen E. Heslop, Cliona M. Rooney, John Wilson, and Ann M. Leen in 2013 and is headquartered in Houston, TX.

Historical Price Data

Date Open High Low Close Volume VWAP
18 Sep 2020 26.160 31.750 25.001 29.580 2,975,560 -
17 Sep 2020 25.000 27.490 24.690 26.050 492,215 -
16 Sep 2020 21.530 25.400 21.410 25.270 581,852 -
15 Sep 2020 21.680 22.343 20.770 21.050 184,871 -
14 Sep 2020 22.470 23.540 21.460 21.500 160,645 -
11 Sep 2020 22.640 22.990 21.570 22.020 83,755 -
10 Sep 2020 23.330 23.960 21.000 22.190 241,144 -
09 Sep 2020 23.980 24.530 23.201 23.730 177,999 -
08 Sep 2020 24.510 25.100 22.315 23.100 251,298 -
04 Sep 2020 28.540 30.110 23.900 24.770 264,835 -
03 Sep 2020 30.910 30.910 27.935 28.150 72,746 -
02 Sep 2020 31.997 32.000 28.750 31.010 122,519 -
01 Sep 2020 31.970 32.280 30.340 31.190 163,565 -
31 Aug 2020 28.290 32.890 28.290 32.390 276,134 -
28 Aug 2020 27.000 29.770 26.960 28.010 172,963 -
27 Aug 2020 32.600 32.650 26.330 26.710 378,300 -
26 Aug 2020 33.370 33.715 31.200 32.800 248,226 -
25 Aug 2020 32.760 33.470 31.160 33.000 351,350 -
24 Aug 2020 33.210 33.500 29.696 32.660 402,994 -
21 Aug 2020 30.680 32.500 30.500 31.760 151,222 -
20 Aug 2020 35.640 36.250 29.270 30.850 290,642 -
19 Aug 2020 35.260 36.750 33.270 36.100 103,838 -
Summary
Current 2 Weeks
(04 Sep 2020 to 18 Sep 2020)
28.540 31.750 20.770 29.580 5,414,174 -
Previous 2 Weeks
(21 Aug 2020 to 03 Sep 2020)
30.680 32.500 20.770 28.150 2,340,019 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.